You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

VERKAZIA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Verkazia, and what generic alternatives are available?

Verkazia is a drug marketed by Harrow Eye and is included in one NDA. There are seven patents protecting this drug.

This drug has one hundred and fifteen patent family members in twenty-three countries.

The generic ingredient in VERKAZIA is cyclosporine. There are eighteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Verkazia

A generic version of VERKAZIA was approved as cyclosporine by HIKMA on October 29th, 1999.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VERKAZIA?
  • What are the global sales for VERKAZIA?
  • What is Average Wholesale Price for VERKAZIA?
Summary for VERKAZIA
International Patents:115
US Patents:7
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 89
Patent Applications: 4,376
Drug Prices: Drug price information for VERKAZIA
What excipients (inactive ingredients) are in VERKAZIA?VERKAZIA excipients list
DailyMed Link:VERKAZIA at DailyMed
Drug patent expirations by year for VERKAZIA
Drug Prices for VERKAZIA

See drug prices for VERKAZIA

US Patents and Regulatory Information for VERKAZIA

VERKAZIA is protected by seven US patents and two FDA Regulatory Exclusivities.

Patents protecting VERKAZIA


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS IN CHILDREN AND ADULTS

Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Compositions containing quaternary ammonium compounds
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Emulsion compositions containing cetalkonium chloride
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

FDA Regulatory Exclusivity protecting VERKAZIA

FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS (VKC) IN CHILDREN AND ADULTS
Exclusivity Expiration: ⤷  Sign Up

NEW PRODUCT
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Harrow Eye VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Harrow Eye VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Harrow Eye VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for VERKAZIA

See the table below for patents covering VERKAZIA around the world.

Country Patent Number Title Estimated Expiration
China 101056615 Ophthalmic oil-in-water type emulsion with stable positive zeta potential ⤷  Sign Up
European Patent Office 1937212 EMULSIONS OPHTALMIQUES CONTENANT DES PROSTAGLANDINES (OPHTHALMIC EMULSIONS CONTAINING PROSTAGLANDINS) ⤷  Sign Up
South Korea 101333923 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for VERKAZIA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1809237 C01809237/01 Switzerland ⤷  Sign Up PRODUCT NAME: CICLOSPORIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66093 08.09.2016
1809237 122015000043 Germany ⤷  Sign Up PRODUCT NAME: OPHTHALMISCHE EMULSION ENTHALTEND CYCLOSPORIN; REGISTRATION NO/DATE: EU/1/15/990 20150319
1809237 CR 2015 00030 Denmark ⤷  Sign Up PRODUCT NAME: CYCLOSPORIN; REG. NO/DATE: EU/1/15/990/001-002 20150323
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.